Faculty

Institution

Unit

Venue

David J. Cole MD

Professor President

Medical University of South Carolina

Affiliations

College of Medicine

Surgery

David J. Cole Md is currently serving as a College Of Medicine Professor President at Medical University of South Carolina.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

David J. Cole MD

Medical University of South Carolina

Professor President

You can click a keyword to filter the displayed items

immunology oncology immune responses cancer research cancer immunotherapy medicine immunotherapy surgery cancer biology pharmacology adaptive immune system tumor biology breast cancer medicinal research surgical oncology clinical immunology cancer treatment cellular immune responses vaccination cancer care molecular diagnostics cellular therapy pancreatic cancer oncogenes cytokines cancer genomics t-regulatory cell breast oncology vaccine development molecular cancer cancer cells tumor targeting novel therapies cancer genetics cell transplantation leukemia cancer detection host response vaccine research peptides cancer discovery immunomodulation general surgery cancer management immunologic mechanisms vaccine design tumor suppressors surgical care molecular immunology lymphocyte development melanoma innate immune system clinical surgery therapeutic vaccines molecular detection micrometastatic breast cancer histopathology respiratory medicine resuscitation virus research dendritic cells peripheral blood biomarker discovery host specificity antigen-specific t-cell response myeloid cells metastatic breast cancer accurate discrimination axillary lymph nodes medical university mammosite breast brachytherapy advanced pancreatic cancer tumor-infiltrating lymphocytes partial breast irradiation clinical cancer stage doxorubicin-cyclophosphamide chemotherapy pathology

Notable Scholarly Works

Notable Federal Grants

Collaborators

The Anti-Proliferative Effects of a Frankincense Extract in a Window of Opportunity Phase Ia Clinical Trial for Patients With Breast Cancer. Breast Cancer Research and Treatment (2024)

Ingrid V. Bonilla ValenteDenise GarciaAndrea AbbottLaura SpruillJulie SiegelJessica ForcucciGeorge HannaRupak MukherjeeMark HamannEleanor HilliardMark LockettDavid J. ColeNancy Klauber-DeMore

anti-proliferative effectspharmacologycancer researchfrankincense extractanti-cancer agentsclinical trialsbreast cancerclinical researchmedicinal researchcancer treatmentopportunity phase

Data From an Innovative Microarray Strategy Identities Informative Molecular Markers for the Detection of Micrometastatic Breast Cancer. (2023)

Kaidi MikhitarianWilliam E. GillandersJonas S. AlmeidaRenee Hebert MartinJuan C. VarelaJohn S. MetcalfDavid J. ColeMichael Mitas

genomicsmolecular markersbiomedical data sciencecancer researchmicroarray data analysiscancer genomicsmolecular diagnosticsbreast cancermicrometastatic breast cancerinnovative diagnosticsdata sciencecancer detectionbioinformatics

The Impact of Nurse Navigation on Timeliness to Treatment for Benign High-Risk Breast Pathology. Breast Cancer Research and Treatment (2023)

Catherine S. BarkerCatherine W. ChungRupak MukherjeeJulie B. SiegelDavid J. ColeMark A. LockettNancy Klauber-DeMoreAndrea M. Abbott

breast cancernurse navigationnursingcancer treatment

Prognostic Factors for Residual Occult Disease in Shave Margins During Partial Mastectomy. Breast Cancer Research and Treatment (2021)

Julie B. SiegelRupak MukherjeeYeonhee ParkAbbie R. CluverCatherine ChungDavid J. ColeMark A. LockettNancy Klauber-DeMoreAndrea M. Abbott

clinical evidencesurvival analysisbreast oncologymedicineprognostic factorscancer carecancer managementshave marginsbreast cancercancer researchsurgical oncologyresidual occult diseasecancer treatmentsurgical pathologybreast surgeryradiologypartial mastectomyradiation oncologycancer imagingoncologyclinical researchmedicinal research

Enhanced Lymphodepletion is Insufficient to Replace Exogenous Il2 or Il15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector Cd8+ T Cells. Cancer Research (2018)

C. Bryce JohnsonBennett R. MayBrian P. RiesenbergSamantha SurianoShikhar MehrotraElizabeth Garrett-MayerMohamed L. SalemEmily K. JengHing C. WongChrystal M. PaulosJohn M. WrangleDavid J. ColeMark P. Rubinstein

immunologycancer careclinical immunologycell therapycancer researchcancer immunotherapycellular therapyoncologycell transplantationcancer treatmenttherapeutic efficacycancer biologyenhanced lymphodepletiontumor biologyimmunotherapycell biology

Il-2 and Beyond in Cancer Immunotherapy. Journal of Interferon & Cytokine Research (2018)

John M. WrangleAlicia PattersonC. Bryce JohnsonDaniel J. NeitzkeShikhar MehrotraChadrick E. DenlingerChrystal M. PaulosZihai LiDavid J. ColeMark P. Rubinstein

pharmacologycytokinescancer immunotherapyoncologyimmunotherapy

Murine Th17 Cells Utilize Il-2 Receptor Gamma Chain Cytokines but Are Resistant to Cytokine Withdrawal-Induced Apoptosis. Cancer Immunology Immunotherapy (2017)

Daniel J. NeitzkeJacob S. BowersKristina AndrijauskaiteNathaniel S. O’ConnellElizabeth Garrett-MayerJohn WrangleZihai LiChrystal M. PaulosDavid J. ColeMark P. Rubinstein

immunologymedicinecell deathcancer immunotherapyapoptosisimmunotherapy

Vaccination With Poly(Ic: Lc) and Peptide-Pulsed Autologous Dendritic Cells in Patients With Pancreatic Cancer. Journal of Hematology & Oncology (2017)

Shikhar MehrotraCarolyn D. BrittenSteve ChinElizabeth Garrett-MayerColleen A. CloudMingli LiGina ScurtiMohamed L. SalemMichelle H. NelsonMelanie B. ThomasChrystal M. PaulosAndres M. SalazarMichael I. NishimuraMark P. RubinsteinZihai LiDavid J. Cole

immunologymedicinepharmacologyhematologypancreatic canceroncologyvaccination

A Feasibility and Safety Study of Vaccination With Poly-Iclc and Peptide-Pulsed Dendritic Cells in Patients With Advanced Pancreatic Adenocarcinoma.. Journal of Clinical Oncology (2016)

Shikhar MehrotraCarolyn D. BrittenSteve Hsukwo ChinMohamed L. SalemColleen CloudMichelle H. NelsonChrystal PaulosElizabeth Garrett-MayerMark P. RubinsteinZihai LiDavid J. Cole

immunologymedical mycologypharmacologycancer careclinical immunologypeptide-pulsed dendritic cellscancer researchcancer immunotherapyvaccine researchoncologyclinical researchvaccinationvaccine safetysafety studyadvanced pancreatic adenocarcinomacellular therapyhealth sciencesclinical mycology

Crossroads-2016 Southeastern Surgical Congress Presidential Address.. PubMed (2016)

David J. Cole

surgerysurgical caremedicinevascular surgeryreconstructive microsurgerysurgical specialtysurgical innovationsurgical educationsurgical oncologyknee surgerysurgical planningsurgical trainingmicrosurgeryorthopaedic surgery

1
2
3
4
5
13
10 / page

David J. Cole MD

Professor President

Medical University of South Carolina

Affiliations

College of Medicine

Surgery

David J. Cole Md is currently serving as a College Of Medicine Professor President at Medical University of South Carolina.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

David J. Cole MD

Medical University of South Carolina

Professor President

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

The Anti-Proliferative Effects of a Frankincense Extract in a Window of Opportunity Phase Ia Clinical Trial for Patients With Breast Cancer. Breast Cancer Research and Treatment (2024)

Ingrid V. Bonilla ValenteDenise GarciaAndrea AbbottLaura SpruillJulie SiegelJessica ForcucciGeorge HannaRupak MukherjeeMark HamannEleanor HilliardMark LockettDavid J. ColeNancy Klauber-DeMore

anti-proliferative effectspharmacologycancer researchfrankincense extractanti-cancer agentsclinical trialsbreast cancerclinical researchmedicinal researchcancer treatmentopportunity phase

Data From an Innovative Microarray Strategy Identities Informative Molecular Markers for the Detection of Micrometastatic Breast Cancer. (2023)

Kaidi MikhitarianWilliam E. GillandersJonas S. AlmeidaRenee Hebert MartinJuan C. VarelaJohn S. MetcalfDavid J. ColeMichael Mitas

The Impact of Nurse Navigation on Timeliness to Treatment for Benign High-Risk Breast Pathology. Breast Cancer Research and Treatment (2023)

Catherine S. BarkerCatherine W. ChungRupak MukherjeeJulie B. SiegelDavid J. ColeMark A. LockettNancy Klauber-DeMoreAndrea M. Abbott

breast cancernurse navigationnursingcancer treatment

Prognostic Factors for Residual Occult Disease in Shave Margins During Partial Mastectomy. Breast Cancer Research and Treatment (2021)

Julie B. SiegelRupak MukherjeeYeonhee ParkAbbie R. CluverCatherine ChungDavid J. ColeMark A. LockettNancy Klauber-DeMoreAndrea M. Abbott

Enhanced Lymphodepletion is Insufficient to Replace Exogenous Il2 or Il15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector Cd8+ T Cells. Cancer Research (2018)

Il-2 and Beyond in Cancer Immunotherapy. Journal of Interferon & Cytokine Research (2018)

John M. WrangleAlicia PattersonC. Bryce JohnsonDaniel J. NeitzkeShikhar MehrotraChadrick E. DenlingerChrystal M. PaulosZihai LiDavid J. ColeMark P. Rubinstein

pharmacologycytokinescancer immunotherapyoncologyimmunotherapy

Murine Th17 Cells Utilize Il-2 Receptor Gamma Chain Cytokines but Are Resistant to Cytokine Withdrawal-Induced Apoptosis. Cancer Immunology Immunotherapy (2017)

Daniel J. NeitzkeJacob S. BowersKristina AndrijauskaiteNathaniel S. O’ConnellElizabeth Garrett-MayerJohn WrangleZihai LiChrystal M. PaulosDavid J. ColeMark P. Rubinstein

immunologymedicinecell deathcancer immunotherapyapoptosisimmunotherapy

Vaccination With Poly(Ic: Lc) and Peptide-Pulsed Autologous Dendritic Cells in Patients With Pancreatic Cancer. Journal of Hematology & Oncology (2017)

immunologymedicinepharmacologyhematologypancreatic canceroncologyvaccination

A Feasibility and Safety Study of Vaccination With Poly-Iclc and Peptide-Pulsed Dendritic Cells in Patients With Advanced Pancreatic Adenocarcinoma.. Journal of Clinical Oncology (2016)

Shikhar MehrotraCarolyn D. BrittenSteve Hsukwo ChinMohamed L. SalemColleen CloudMichelle H. NelsonChrystal PaulosElizabeth Garrett-MayerMark P. RubinsteinZihai LiDavid J. Cole

Crossroads-2016 Southeastern Surgical Congress Presidential Address.. PubMed (2016)

David J. Cole

1
2
3
4
5
13
10 / page

Similar Faculty Members

Olivera J. Finn

Institution

University of Pittsburgh

cancer letter

immunotherapy

Zihai Li

Institution

Medical University of South Carolina

immunology

immunotherapy

Walter J. Storkus

Institution

University of Pittsburgh

immunomodulation

tumor immunobiology

William Hawkins, M.D

Institution

Medical University of South Carolina

cancer research

oncology

Pawel Kalinski

Institution

University of Pittsburgh

immunology

oncology

Hideho Okada

Institution

University of California, San Francisco

brain tumor research

malignant disease

Samir Parekh

Institution

Icahn School of Medicine at Mount Sinai

immunology

oncology

Craig Slingluff

Institution

University of Virginia

cancer vaccines

melanoma

Lawrence Fong

Institution

University of California, San Francisco

malignant disease

cancer immunotherapy

David Geller

Institution

University of Pittsburgh

oncology

surgery

Similar Faculty Members

Olivera J. Finn

Institution

University of Pittsburgh

cancer letter

immunotherapy

Zihai Li

Institution

Medical University of South Carolina

immunology

immunotherapy

Walter J. Storkus

Institution

University of Pittsburgh

immunomodulation

tumor immunobiology

William Hawkins, M.D

Institution

Medical University of South Carolina

cancer research

oncology

Pawel Kalinski

Institution

University of Pittsburgh

immunology

oncology

Hideho Okada

Institution

University of California, San Francisco

brain tumor research

malignant disease

Samir Parekh

Institution

Icahn School of Medicine at Mount Sinai

immunology

oncology

Craig Slingluff

Institution

University of Virginia

cancer vaccines

melanoma

Lawrence Fong

Institution

University of California, San Francisco

malignant disease

cancer immunotherapy

David Geller

Institution

University of Pittsburgh

oncology

surgery